MedPath

Medical University of Vienna

Medical University of Vienna logo
🇦🇹Austria
Ownership
Private
Established
1365-01-01
Employees
1K
Market Cap
-
Website
http://www.meduniwien.ac.at

Hemopatch for Prevention of Bile Leaks After Liver Resection

Not Applicable
Conditions
Bile Leak
Interventions
Device: HEMOPATCH Sealing Hemostat
First Posted Date
2018-11-27
Last Posted Date
2019-10-25
Lead Sponsor
Medical University of Vienna
Target Recruit Count
71
Registration Number
NCT03753880
Locations
🇦🇹

Medical University Vienna, Vienna, Austria

The Vienna Prograf and Endothelial Progenitor Cell Extension Study

Phase 4
Completed
Conditions
Renal Failure
Immunosuppression
Interventions
First Posted Date
2018-11-23
Last Posted Date
2018-11-23
Lead Sponsor
Medical University of Vienna
Target Recruit Count
87
Registration Number
NCT03751332

The Impact of Non-pulsatile Blood Flow on CO2-Reactivity

Not Applicable
Completed
Conditions
Cerebrovascular Circulation
Interventions
Procedure: alteration of PaCO2 level
First Posted Date
2018-11-06
Last Posted Date
2018-11-06
Lead Sponsor
Medical University of Vienna
Target Recruit Count
32
Registration Number
NCT03732651
Locations
🇦🇹

medical University of Vienna, Vienna, Austria

Adherence to Prescribed Medication: Elucidating the Gap Between Guideline Recommendation and Real Life in Myocardial Infarction

Conditions
Myocardial Infarction
Adherence, Medication
First Posted Date
2018-09-07
Last Posted Date
2019-08-14
Lead Sponsor
Medical University of Vienna
Target Recruit Count
300
Registration Number
NCT03661710
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

Lateral Suspension Versus Sacral Colpopexy POP

Not Applicable
Not yet recruiting
Conditions
Pelvic Organ Prolapse
Interventions
Procedure: Laparoscopic repair of anterior and apical pelvic organ prolapse
First Posted Date
2018-08-23
Last Posted Date
2018-09-19
Lead Sponsor
Medical University of Vienna
Target Recruit Count
200
Registration Number
NCT03644628

Changes in Adaptive Immune Responses and Effector Cell Responses Upon Nasal Allergen Exposure - a Pilot Study

Not Applicable
Completed
Conditions
Allergic Rhinitis
Allergic Inflammation
Interventions
Diagnostic Test: Nasal Provocation with Birch Extract
Other: Nasal Provocation with NaCl 0.9%
First Posted Date
2018-08-23
Last Posted Date
2019-10-10
Lead Sponsor
Medical University of Vienna
Target Recruit Count
36
Registration Number
NCT03644680
Locations
🇦🇹

8H1.02, ENT Lab, Department of Otorhinolaryngology, Vienna General Hospital, Vienna, Austria

Implantable MyoElectric Sensors (IMES) for Prosthetic Control in Transhumeral Amputees

Not Applicable
Completed
Conditions
Amputation
Interventions
Device: Implantation of IMES sensors
First Posted Date
2018-08-23
Last Posted Date
2018-08-23
Lead Sponsor
Medical University of Vienna
Target Recruit Count
3
Registration Number
NCT03644394

Image Guided IMRT, Radiochemotherapy and MRI-based IGABT in Locally Advanced Cervical Cancer

Phase 2
Recruiting
Conditions
Uterine Cervical Neoplasms
Interventions
Radiation: Increased use of IC/IS technique in BT
Radiation: Reduction of vaginal source loading
Radiation: Systematic utilisation of IMRT
Radiation: Utilisation of daily IGRT (set-up according to bony structures)
Radiation: EBRT target concept related to the primary tumor (CTV-T) and internal motion; concepts for OAR contouring
Radiation: EBRT dose prescription and reporting
Radiation: Adaptation of EBRT nodal elective CTV according to risk of nodal and systemic recurrence
Drug: Systemic application of simultaneous chemotherapy
Other: Reduction of overall treatment time
First Posted Date
2018-08-06
Last Posted Date
2022-03-17
Lead Sponsor
Medical University of Vienna
Target Recruit Count
1000
Registration Number
NCT03617133
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

The Relationship of the Intestinal Microbiome and the Menstrual Cycle

Conditions
Sex Hormones
Microbial Colonization
Interventions
Diagnostic Test: Laboratory measurements
Diagnostic Test: Stool samples
Diagnostic Test: Bioimpedance analysis
First Posted Date
2018-07-10
Last Posted Date
2019-09-03
Lead Sponsor
Medical University of Vienna
Target Recruit Count
20
Registration Number
NCT03581201
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

CTA Expression/Methylation and Response to Pembrolizumab of NSCLC Patients

Phase 2
Conditions
Non Small Cell Lung Cancer
Interventions
Other: PD-L1 positive vs PD-L1 negative NSCLC patients
First Posted Date
2018-06-27
Last Posted Date
2020-06-11
Lead Sponsor
Medical University of Vienna
Target Recruit Count
42
Registration Number
NCT03571360
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath